Enliven Therapeutics (ELVN) Stock Chart & Stock Price History $20.82 -0.47 (-2.21%) Closing price 10/10/2025 04:00 PM EasternExtended Trading$20.76 -0.05 (-0.26%) As of 10/10/2025 04:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Enliven Therapeutics Stock Price Performance The Enliven Therapeutics (ELVN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 25.40%, with a year-to-date return of -7.47%. In the past month, the stock has increased 4.52%, reflecting recent market activity. As of the latest close, Enliven Therapeutics traded at $20.82 with a market cap of $1.23 billion and volume of 546,587 shares. Receive ELVN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+2.56%1 Month Performance+4.52%3 Month Performance-7.26%Year-To-Date Performance-7.47%1 Year Performance-25.40% ELVN Stock Chart for Saturday, October, 11, 2025 ELVN Chart by TradingView Enliven Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/10/2025$21.29$20.82-2.21%$21.31$20.59546,587 shs$1.23 billion10/09/2025$20.32$21.29+4.77%$21.81$20.24877,100 shs$1.26 billion10/08/2025$20.11$20.32+1.04%$20.97$20.09365,363 shs$1.20 billion10/07/2025$20.30$20.11-0.94%$20.40$20.00275,263 shs$1.19 billion10/06/2025$19.61$20.30+3.52%$20.66$19.48340,737 shs$1.20 billion10/03/2025$19.92$19.61-1.56%$20.19$19.00313,903 shs$1.16 billion10/02/2025$19.83$19.92+0.45%$20.09$19.11267,636 shs$1.18 billion10/01/2025$20.47$19.83-3.13%$20.65$19.76289,888 shs$1.17 billion09/30/2025$20.30$20.47+0.84%$20.90$19.97402,428 shs$1.21 billion09/29/2025$20.01$20.30+1.45%$20.74$20.02374,036 shs$1.20 billion Get the Latest News and Ratings for ELVN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 09/26/2025$18.57$20.01+7.75%$20.55$18.28521,732 shs$1.19 billion09/25/2025$19.20$18.57-3.28%$19.08$18.47277,472 shs$1.10 billion09/24/2025$19.19$19.20+0.05%$19.51$18.87470,065 shs$1.14 billion09/23/2025$19.92$19.19-3.66%$20.11$19.08433,561 shs$1.14 billion09/22/2025$18.96$19.92+5.06%$20.03$18.50423,260 shs$1.18 billion09/19/2025$19.92$18.96-4.82%$20.22$18.912.31 million shs$1.12 billion09/18/2025$19.02$19.92+4.73%$19.99$18.781.31 million shs$1.18 billion09/17/2025$18.43$19.02+3.20%$19.50$18.57560,706 shs$1.13 billion09/16/2025$18.50$18.43-0.38%$19.07$18.01580,713 shs$1.09 billion09/15/2025$19.96$18.50-7.31%$20.30$18.11624,244 shs$1.10 billion09/12/2025$19.92$19.96+0.20%$20.15$19.26618,497 shs$1.18 billion09/11/2025$19.22$19.92+3.64%$19.97$18.80633,330 shs$1.18 billion09/10/2025$19.72$19.22-2.54%$20.24$19.04369,670 shs$1.14 billion Related Companies PTC Therapeutics Stock Chart Jyong Biotech Stock Chart Arrowhead Pharmaceuticals Stock Chart Arcellx Stock Chart Vaxcyte Stock Chart Crinetics Pharmaceuticals Stock Chart Protagonist Therapeutics Stock Chart Kymera Therapeutics Stock Chart MoonLake Immunotherapeutics Stock Chart Akero Therapeutics Stock Chart Receive ELVN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enliven Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ELVN) was last updated on 10/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enliven Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enliven Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
